ReviewClinical & experimental metastasis2026
What we can learn from the lepidic growth pattern of pulmonary metastases.
Review in Clinical & experimental metastasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In lung adenocarcinoma, cancer cells can grow in a peculiar modality, replacing normal pneumocytes and creating glandular-like structures based on the alveolar architecture. This lepidic growth pattern is characterized by well differentiated epithelial cancer cells, that preserve their monolayer disposition, avoiding invasion of the interstitial space and dispersion into the airways. The same growth pattern can be assumed also by cancer cells originating from distant organs and a new interest has arisen around this modality of growth related to pulmonary metastases. Here we systematically reviewed the current literature about reports describing pulmonary metastases with a lepidic pattern and their clinical management. Although the small number of cases does not allow definitive conclusions about the frequency and clinical relevance, the existence of this peculiar manifestation reinforces the idea that metastatic disease is more complex and heterogeneous than is conveyed by the clinical guidelines.
Indexed as
Identifiers
41524824What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.